Dan Roden
Faculty Member
Last active: 3/24/2020

Inactivating mutations in NPC1L1 and protection from coronary heart disease.

Myocardial Infarction Genetics Consortium Investigators, Stitziel NO, Won HH, Morrison AC, Peloso GM, Do R, Lange LA, Fontanillas P, Gupta N, Duga S, Goel A, Farrall M, Saleheen D, Ferrario P, K├Ânig I, Asselta R, Merlini PA, Marziliano N, Notarangelo MF, Schick U, Auer P, Assimes TL, Reilly M, Wilensky R, Rader DJ, Hovingh GK, Meitinger T, Kessler T, Kastrati A, Laugwitz KL, Siscovick D, Rotter JI, Hazen SL, Tracy R, Cresci S, Spertus J, Jackson R, Schwartz SM, Natarajan P, Crosby J, Muzny D, Ballantyne C, Rich SS, O'Donnell CJ, Abecasis G, Sunaev S, Nickerson DA, Buring JE, Ridker PM, Chasman DI, Austin E, Kullo IJ, Weeke PE, Shaffer CM, Bastarache LA, Denny JC, Roden DM, Palmer C, Deloukas P, Lin DY, Tang ZZ, Erdmann J, Schunkert H, Danesh J, Marrugat J, Elosua R, Ardissino D, McPherson R, Watkins H, Reiner AP, Wilson JG, Altshuler D, Gibbs RA, Lander ES, Boerwinkle E, Gabriel S, Kathiresan S
N Engl J Med. 2014 371 (22): 2072-82

PMID: 25390462 · PMCID: PMC4335708 · DOI:10.1056/NEJMoa1405386

MeSH Terms (21)

Adult African Continental Ancestry Group Asian Continental Ancestry Group Case-Control Studies Cholesterol, LDL Coronary Disease European Continental Ancestry Group Exons Female Gene Silencing Genotype Humans Male Membrane Proteins Membrane Transport Proteins Middle Aged Mutation Protein Conformation Risk Sequence Analysis, DNA Triglycerides

Connections (2)

This publication is referenced by other Labnodes entities:

Links